Founded in 2014, Magellan Life Sciences operates in Health Tech offering industrial scale manufacturing processes of proteins through its proprietary synthetic biology bacterial platform. The company ...
Funding stage:
Seed
Last funding:
29/04/2019
Investors
Employee count:
2
Last 90d
2
Last 90d
Magellan Life Sciences: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders2
Latest Filing Date30 March 2022- Funding Events10
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Magellan Life Sciences
As of 31 March 2022, Magellan Life Sciences's equity is held by 2 shareholders, with the top three being Abhiram Dukkipati and Nageswararao Dukkipati.
Abhiram Dukkipati holds the largest stake in Magellan Life Sciences at 90.0% as of 31 March 2022.
As of 31 March 2022, founders collectively hold 100.0% equity in Magellan Life Sciences.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links